Workflow
Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia
Globenewswire· 2025-11-04 15:45
STOCKHOLM, SWEDEN November 4, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company, Modus Therapeutics, has received regulatory approval to initiate the second part of the phase 2 study with sevuparin as a treatment of chronic kidney disease with anemia. The study will be initiated in Q4 2025, in line with the company’s development timeline. Modus Therapeutics, listed on Nasdaq First North Growth Market, has received approval from regulatory authorities in Ital ...
Temenos Earns 2025 Great Place To Work Certification™ Across 15 Locations
Globenewswire· 2025-11-04 15:39
公司认证成就 - 公司Temenos在2025年获得Great Place to Work®认证的地点总数达到15个[1] - 近期新增的5个认证地点包括美国、印度、厄瓜多尔、香港和台湾[1] - 公司在美国的战略扩张包括在佛罗里达州中部设立创新中心[3] - 公司在印度连续第二年获得认证,反映出对其产品、创新和工程中心的持续投资[4] 公司文化与员工体验 - 公司文化被视为成功的关键支柱,强调激情、协作和团队承诺[3] - 公司通过灵活工作政策、包容性领导力项目以及关注多元化和福祉等举措优先提升员工体验[5] - 公司致力于营造一个由赋权和问责制塑造的包容性环境,使每位同事都能产生影响[3] - 公司在印度通过长期的企业社会责任项目展示了强大的人员参与本地文化[4] 认证带来的积极影响 - 获得认证完全基于这些地点员工的反馈,确认公司是一个理想的工作场所[2] - 在获得认证的公司中,求职者找到优秀经理的可能性高出4.5倍[6] - 认证工作场所的员工期待上班的可能性高出93%,获得公平薪酬和晋升机会的可能性是两倍[6]
AS Tallink Grupp Statistics for October 2025
Globenewswire· 2025-11-04 15:00
In October 2025, AS Tallink Grupp transported 467,279 passengers, which is a 2.5% decrease compared to October 2024. The number of cargo units decreased by 10.2% to 21,855 units and the number of passenger vehicles decreased by 2.6% to 58,006 units compared to the same period a year ago. AS Tallink Grupp passenger, cargo unit and passenger vehicle numbers for October 2025 were the following: October 2025October 2024ChangePassengers467,279479,232-2.5%Finland - Sweden137,011135,1191.4%Estonia - Finland286,55 ...
Eurocastle announces Director resignation
Globenewswire· 2025-11-04 15:00
EUROCASTLE INVESTMENT LIMITED FOR IMMEDIATE RELEASEContact: Oak Fund Services (Guernsey) LimitedCompany AdministratorAttn: Nicole BarnesTel: +44 1481 752957 Eurocastle Announces Resignation of Mr. Constantine (Dean) Dakolias from Board of Directors Guernsey, 4 November 2025 – Eurocastle Investment Limited (Euronext Amsterdam: ECT) today announces that Mr. Constantine (Dean) Dakolias retired as a non-independent director of the Company, effective 3 November 2025. The Board extends its sincere gratitude f ...
Equinor ASA: Share buy-back – fourth tranche for 2025
Globenewswire· 2025-11-04 15:00
Please see below information about transactions made under the fourth tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the buy-back tranche was announced: 29 October 2025. The duration of the buy-back tranche: 30 October to no later than 2 February 2026. Further information on the tranche can be found in the stock market announcement on its commencement dated 29 October 2025, available here: https://newsweb.oslobors.no/message/658157 F ...
Elis: Disclosure of trading in own shares occured from October 28 to October 31, 2025
Globenewswire· 2025-11-04 15:00
Disclosure of trading in own shares occurred from October 28 to October 31, 2025 Saint-Cloud, November 4, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from October 28 to October 31, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction da ...
Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25
Globenewswire· 2025-11-04 14:32
Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25 FY 2024/25 organic growth of 7% and EBIT margin1 of 28%. Reported revenue in DKK grew 3% to DKK 27,874 million.• Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice & Respiratory Care 9%, Wound & Tissue Repair 8% and Interventional Urology 2%.• EBIT1,2 was DKK 7,670 million, a 5% increase from last year. The EBIT margin1,2 was 28%, against 27% last year.• Adjusted3 net profit before special items was DKK 5,148 m ...
Coloplast A/S - Full-Year Financial Results 2024/25
Globenewswire· 2025-11-04 14:31
2024/25Full year financial results 1 October 2024 - 30 September 2025 Coloplast delivered Q4 organic growth of 7% and an EBIT margin1 of 28%. Reported revenue in DKK grew 0% with negative impact from currencies and the Skin Care divestment.• Organic growth rates by business area: Ostomy Care 7%, Continence Care 9%, Voice & Respiratory Care 9%, Wound & Tissue Repair 5% and Interventional Urology 2%.• Growth in Ostomy Care was broad based with good contribution from recent product launches and led by Europe a ...
International Petroleum Corporation Announces Third Quarter 2025 Financial and Operational Results and Blackrod Phase 1 Development Progressing Ahead of Schedule
Globenewswire· 2025-11-04 14:30
核心观点 - 国际石油公司2025年第三季度运营表现强劲 平均净产量高于指导范围 Blackrod项目第一阶段开发进度超前 [1][2][3] - 公司通过债券再融资和股票回购优化资本结构 并计划延续股东回报策略 [4][24][26] - 尽管面临油价波动等宏观挑战 公司维持2025年全年产量指引 并对中长期行业基本面持建设性观点 [6][8][9] 运营业绩 - 2025年第三季度平均净产量约为每日45,900桶油当量 超出指导范围 其中重质原油占53% 轻质和中质原油占14% 天然气占33% [2][7] - Onion Lake Thermal资产按计划完成生产加密井的投产 [7] - 第三季度每桶油当量运营成本为179美元 略低于指导值 [7][15] - 2025年全年平均净产量指导范围维持在每日43,000至45,000桶油当量 [6][14] Blackrod项目进展 - Blackrod项目第一阶段开发进度超前 首次注汽预计在2025年底 首次产油预计在2026年第三季度 比原计划提前一个季度 [1][3] - 项目中心处理设施建设接近完成 逐步调试工作进展顺利 [3][21] - 由于启动时间提前 最后一个井场的钻探已加速至2025年第四季度进行 [3][22] - 项目增长资本预算保持为850百万美元 截至第三季度末已发生支出785百万美元 占首油前总预算的92% [3][20] 财务表现 - 2025年第三季度营业收入为172,297千美元 九个月累计营业收入为509,681千美元 [8] - 第三季度运营现金流为66,102千美元 符合指引 九个月累计运营现金流为195,765千美元 [7][8][15] - 第三季度资本和弃置支出为82,000千美元 符合指引 [7][16] - 第三季度自由现金流为-23,083千美元 若扣除Blackrod资本支出则为36,000千美元 [7][17] - 第三季度净利润为3,802千美元 九个月累计净利润为33,883千美元 [8] - 截至2025年9月30日 总现金为45,000千美元 净债务为435,000千美元 [7][18] 资本管理与股东回报 - 公司在第三季度成功完成2024/2025年度正常程序发行人回购 期间共回购并注销约750万股普通股 相当于2024年12月初流通股的62% [4][7][24] - 公司计划在2025年12月寻求多伦多证券交易所批准 续期下一轮NCIB 预计可进一步回购约650万股普通股 约占当前流通股的58% [7][26] - 公司于2025年10月成功完成450百万美元无担保债券的再融资 新债券期限至2030年10月 票面利率为75% [4][19] 市场环境与对冲 - 2025年第三季度布伦特原油平均价格约为每桶69美元 相对稳定 [8] - 公司对约50%的2025年预测石油产量进行了对冲 布伦特和WTI价格分别约为每桶76美元和71美元 [10] - 第三季度WTI与WCS价差平均低于每桶11美元 公司已对约50%的2025年预测加拿大石油产量进行了价差对冲 价格为每桶14美元 [11] - 公司对约50%的2025年10月底前净多头天然气风险敞口进行了对冲 价格为每千立方英尺24加元 [13] 2025年全年指引更新 - 全年运营成本指导范围维持在每桶油当量180至190美元 [12][15] - 全年运营现金流指导范围收窄至245至255百万美元 假设2025年剩余时间布伦特油价为每桶55至65美元 [12][15] - 全年资本和弃置支出指导从320百万美元修订为340百万美元 主要由于Blackrod项目钻探活动提前 [12][16] - 全年自由现金流指导修订为-170至-160百万美元 假设2025年剩余时间布伦特油价为每桶55至65美元 [12][17]
Zelluna ASA: Disclosure of large shareholding
Globenewswire· 2025-11-04 14:29
Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the "Private Placement"), divided on a first tranche of 3,729,774 new shares ("Tranche 1") and a second tranche of 1,770,226 new shares, and the allocation of 315,639 new shares in a retail offering via the PrimaryBid Platform (the "Retail Offering"). Radforsk Investeringsstiftelse ("Radforsk") holds 2,469,693 sha ...